Corrigendum to 'Nafamostat protects against early brain injury after subarachnoid hemorrhage in mice' [Journal of Pharmacological Sciences 148 (2022) 65-72]
1 Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan; Department of Neurosurgery, Gifu University Graduate School of Medicine, Gifu, Japan.
2 Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan.
3 Department of Neurosurgery, Gifu University Graduate School of Medicine, Gifu, Japan.
4 Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan. Electronic address: hidehara@gifu-pu.ac.jp.